Judge Dismisses Pfizer From States' Broad Antitrust Case Over Generic Drug Pricing
A federal judge in Connecticut has removed Pfizer as a defendant from a large antitrust suit brought by most U.S. states, finding that prosecutors did not present sufficient evidence that Pfizer conspired with rivals via its former Greenstone unit to rig bids or allocate customers for a set of generic drugs between 2010 and 2014.